Your Article Summary
See Latest ArticlesEfficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: An observational study
Clinical Reviews in Allergy and Immunology, 06/30/09
Filippini M et al. – Study shows that anti-TNFα treatment reduced disease activity and led to functional improvement in both elderly and younger patients, although the baseline difference in HAQ remained statistically significant at the end of the follow-up. The elderly patients experienced more infective events.
Methods- A comparison of the efficacy and safety of anti-TNF agents in elderly (aged ≥65 yrs) and younger pts (aged 18–65 yrs) with active RA
- 1,114 RA pts, followed-up for >6 mo, were divided into 2 cohorts on the basis of their age to evaluate 3-yr outcomes and treatment discontinuations
- Drug effectiveness was assessed by DAS28 and EULAR response, functional status (HAQ) and serological parameters (ESR) at baseline and during therapy
- Safety was evaluated on the basis of drug discontinuation rates
- At baseline, the elderly pts showed greater disease activity and loss of joint function
- During therapy, clinical and laboratory parameters improved in both groups w/o any difference between them
- Difference in HAQ remained after 36 mo of treatment
- Anti-TNFα therapy was discontinued by 42% elderly and 36.6% of younger pts because of loss of efficacy, severe adverse events or other reasons
- Number of AEs was higher in the elderly patients
Related Articles
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 70%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 69%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis
Rheumatology International, 12/16/09
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09
Klinefelters syndrome and rheumatoid arthritis: report of a case and review of the literature
International Journal of Rheumatic Diseases, 12/15/09
A Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for Efficient Capture of Essential Data from a Patient and a Health Professional in a Uniform Scientific Format
Rheumatic Disease Clinics of North America, 12/14/09